ArticleACS pharmacology & translational science2020

Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19.

Bapurao Surnar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.